The new regulations for assisted reproductive technology in India were introduced in 2020 through the Assisted Reproductive Technology (ART) Regulation Bill. The implications of these regulations on the cost and success rate of infertility treatments in India are as follows:

• The bill mandates that all infertility clinics and ART banks in India must be registered with the National Board under the Ministry of Health and Family Welfare. This will ensure that only qualified and ethical professionals are involved in ART treatment and that the sperm, egg, and embryo donation process is regulated and transparent.
• This regulation may increase the cost of ART treatments in India as clinics may have to invest in quality control measures and require more staff to meet the compliance requirements. The costs may also increase due to the restriction on the number of embryos that can be implanted to prevent multiple pregnancies.
• The success rates of ART treatments, however, may increase due to the stricter standards and better quality control measures. This will ensure that only healthy embryos are implanted, increasing the chances of a successful pregnancy.
• The bill prohibits any form of sex selection during ART treatments, except in cases of genetic diseases. This will help in preventing the skewed sex ratio in India, where female feticide is a prevalent problem.

Overall, the new regulations for assisted reproductive technology in India will ensure better standards of care and ethical practices in infertility treatments, but may also lead to increased costs for patients.